Xtant Medical Holdings, Inc. (XTNT) stock
XTNTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 9/3080% below fair value
$0.21−0.00 (-2.19%)
Close on Nov 17, 2026Market cap $28.79MP/E –Yield –
Xtant Medical operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Xtant Medical's operating income for the twelve months ending Jun 30, 2026 was -$10.50M, down 37582.1% year over year. For fiscal 2025 it was $7.28M. The highest annual figure on record is $7.28M in fiscal 2025.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.28M | – |
| FY2024 | Dec 31, 2024 | -$12.07M | – |
| FY2023 | Dec 31, 2023 | -$10.16M | – |
| FY2022 | Dec 31, 2022 | -$6.76M | – |
| FY2021 | Dec 31, 2021 | -$3.85M | – |
| FY2020 | Dec 31, 2020 | -$751.00K | – |
| FY2019 | Dec 31, 2019 | -$2.25M | – |
| FY2018 | Dec 31, 2018 | -$60.08M | – |
| FY2017 | Dec 31, 2017 | -$37.83M | – |
| FY2016 | Dec 31, 2016 | -$7.55M | – |
| FY2015 | Dec 31, 2015 | -$12.08M | – |
| FY2014 | Dec 31, 2014 | -$6.26M | – |
| FY2013 | Dec 31, 2013 | -$9.01M | – |
| FY2012 | Dec 31, 2012 | -$4.94M | – |
| FY2011 | Dec 31, 2011 | -$6.45M | – |
| FY2010 | Dec 31, 2010 | -$8.61M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$9.17M | -298.3% |
| Q1 FY2026 | Mar 31, 2026 | -$2.92M | -375.0% |
| Q4 FY2025 | Dec 31, 2025 | -$944.00K | – |
| Q3 FY2025 | Sep 30, 2025 | $2.54M | – |
| Q2 FY2025 | Jun 30, 2025 | $4.62M | – |
| Q1 FY2025 | Mar 31, 2025 | $1.06M | – |
| Q4 FY2024 | Dec 31, 2024 | -$1.88M | – |
| Q3 FY2024 | Sep 30, 2024 | -$3.78M | – |
| Q2 FY2024 | Jun 30, 2024 | -$2.95M | – |
| Q1 FY2024 | Mar 31, 2024 | -$3.47M | – |
| Q4 FY2023 | Dec 31, 2023 | -$3.81M | – |
| Q3 FY2023 | Sep 30, 2023 | -$3.39M | – |
| Q2 FY2023 | Jun 30, 2023 | -$1.39M | – |
| Q1 FY2023 | Mar 31, 2023 | -$1.58M | – |
| Q4 FY2022 | Dec 31, 2022 | -$1.72M | – |
| Q3 FY2022 | Sep 30, 2022 | -$1.90M | – |
| Q2 FY2022 | Jun 30, 2022 | -$1.30M | – |
| Q1 FY2022 | Mar 31, 2022 | -$1.83M | – |
| Q4 FY2021 | Dec 31, 2021 | -$1.91M | -896.3% |
| Q3 FY2021 | Sep 30, 2021 | -$1.45M | -290.1% |
| Q2 FY2021 | Jun 30, 2021 | -$491.00K | – |
| Q1 FY2021 | Mar 31, 2021 | -$5.00K | – |
| Q4 FY2020 | Dec 31, 2020 | $240.00K | – |
| Q3 FY2020 | Sep 30, 2020 | $760.00K | – |
| Q2 FY2020 | Jun 30, 2020 | -$387.00K | – |
| Q1 FY2020 | Mar 31, 2020 | -$1.36M | – |
| Q4 FY2019 | Dec 31, 2019 | -$318.00K | – |
| Q3 FY2019 | Sep 30, 2019 | -$705.00K | – |
| Q2 FY2019 | Jun 30, 2019 | -$563.00K | – |
| Q1 FY2019 | Mar 31, 2019 | -$668.00K | – |
| Q4 FY2018 | Dec 31, 2018 | -$54.73M | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.44M | – |
| Q2 FY2018 | Jun 30, 2018 | -$2.26M | – |
| Q1 FY2018 | Mar 31, 2018 | -$1.66M | – |
| Q4 FY2017 | Dec 31, 2017 | -$24.24M | – |
| Q3 FY2017 | Sep 30, 2017 | -$4.69M | – |
| Q2 FY2017 | Jun 30, 2017 | -$6.35M | – |
| Q1 FY2017 | Mar 31, 2017 | -$2.57M | – |
| Q4 FY2016 | Dec 31, 2016 | -$1.16M | – |
| Q3 FY2016 | Sep 30, 2016 | -$1.90M | – |
See a number that looks wrong?